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Introduction
In order to effectively defend the body against in­
fectious organisms, cells of the immune system 
should be able to circulate as non-adherent cells in 
blood and lymph, and to migrate as adherent cells 
throughout the tissues. To arrive at sites of infection 
and to adhere to target cells bearing foreign antigen, 
cells need to cross endothelial and vessel walls. To 
control this rapid transition between adherent and 
non-adherent states, lymphocytes are equipped with 
different adhesion receptors. Integrins form a major 
group of adhesion receptors mediating the adhesion 
events of lymphocytes with antigen-bearing cells as 
well as between lymphocytes and endothelial cells 
(fig. 1). Lymphocytes express several integrin 
molecules at their cell surface which may all partici­
pate in the same intercellular interaction. Apart from 
integrins, lymphoid cells express other adhesion 
receptors which may regulate cell adhesion or con­
tribute to the integrin-mediated cell-cell interaction. 
Cloning of the genes encoding these molecules and 
their counterreceptors revealed that they belong to 
distinct families of structurally related proteins : the 
selectins, immunoglobulin superfamily and the CD44 
adhesion receptor (fig. 1). Here we focus on integrin- 
mediated adhesion of lymphocytes; therefore, only 
integrins will be discussed in detail.
Integrins expressed on lymphocytes and their ligands
All integrins are heterodimers composed of an 
a-subunit non-covalently associated with a (3-subunit 
(Hynes, 1987). Eight different (3-subunits and four­
teen different a-subunits have been identified thus 
far. Many distinct a-subunits can associate with only 
one (3-subunit (Rouslahti, 1991 ; Hynes, 1992). In ad­
dition, certain a-subunits can associate with differ­
ent (3-subunits (Holzmann and Weissman, 1989; 
Hemler, 1990). Based on shared (3-subunits, subfa­
milies can be distinguished within the integrin fami­
ly. Only the molecules belonging to the (31, (32 and 
(37 subfamilies are expressed on lymphocytes (table I), 
and will be discussed below.
The (3/ integrins are also called VLA (very late ac­
tivation antigens). Thus far, eight members of this 
group are defined. They are expressed on a wide 
variety of cells, including non-haematopoietic cells 
(Hemler, 1990; Hemler et aL} 1990; Hemler, 1988). 
Most VLA bind to extracellular matrix (ECM) com ­
ponents such as fibronectin (FN), laminin (LM) and 
collagen (Coll), and thus play a role in lymphocyte 
adhesion and migration into tissues (Shimizu et a l ., 
1991; Rouslahti and Pierschbacher, 1987). VLA-4 
(CD49d/CD29) is the only member of the (31 inte­
grins which recognizes, apart from the ECM com­
ponent FN, a transmembrane molecule. VCAM-1 
(vascular cell adhesion molecule-1) (Osborn et a i ,  
1989; Elices et a!., 1990) the ligand of VLA-4, is ex­
pressed by activated endothelium (fig. 1). Therefore, 
VLA-4 is also involved in lymphocyte-endothelial cell 
interactions. The site on the ligands recognized by 
many VLA contains the sequence RGD or EILDV 
(Rouslahti and Pierschbacher, 1986; Wayner et al.,
1989).
The (32 integrins are also called the Leu-Cam fa­
mily (leukocyte ceil adhesion molecules), since their 
expression is restricted to leukocytes (T and B lym­
phocytes, monocytes, granulocytes), in contrast to 
all other integrin families. This group consist of three 
members: LFA-1, CR3 (or Mac-1) and p 150,95 
(Sanchez-Madrid et a i ,  1982; Keizer et a i ,  1985).
LFA-1 (leukocyte-function-associated antigen-1) 
consists of a 180-kDa a-subunit (C D lla )  and a 
95-kDa (3-subunit (CD 18) (Kurzinger et al,3 1981), 
and is expressed on all leukocytes. It is involved in 
a broad range o f  leukocyte functions such as T-cell- 
mediated killing, T helper cell and B-cell responses, 
natural killer cell activity, monocyte-mediated 
antibody-dependent cytotoxicity and leukocyte adhe­
sion to endothelial cells (Springer, 1990; Martz, 
1987). The involvement of LFA-1 in all these 
responses has been revealed by monoclonal anti­
bodies directed against LFA-1 that inhibit these 
processes (Krensky et a i , 1983). LFA-1 mediates cell­
cell interaction through binding of one o f its three 
counterreceptors, ICAM-1 (intercellular adhesion 
molecule-1) (Marlin and Springer, 1987), ICAM-2
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Fig. 1. Multiple adhesion receptors can contribute to the interaction of lymphocytes with endotheli­
al cells (A) or of lymphocytes with leukocytes (T, B lymphocytes, monocytes and dendritic cells) (B).
Different families of adhesion molecules can be distinguished: blank = integrins, hatched = 
immunoglobulins, cross-hatched -  selectins, stippled = unclassified molecules.
Table I. Integrins expressed on lymphocytes.
Distribution
haemopoietically
Subunit Names C D restricted Counterstructure
ßl «1 V L A -1 C D 49a/C D 29 no LM, Coll
<x2 V L A -2 C D 49b/C D 29 no LM, Coll
«3 VLA-3 CD49c/CD29 no LM, Coll, FN
a4 VLA-4 C D 49d/C D 29 no FN, VCAM-1
«5 VLA-5 C D 49e/C D 29 no FN
a6 VLA -6 C D 49f/C D 29 no LM
ß2 aL LFA-1 CD1 la /C D 1 8 yes ICAM-1, -2, -3
aM Mac-1, CR3 C D 1 lb /C D 18 yes ICAM-1, FG, fc X, C3bi
ocX pl50,95 C D l lc /C D 1 8 yes FG, C3bi
ß7 «4 -------- C D 49d/C D - yes FN, VCAM-1
aHML yes ■?•
Abbreviations used: Coll (collagen), fc X (factor X), FG (fibronigen), FN (fibronectin) and LM (laminin).
ADHESION MOLECULES IN LEUKOCYTE-ENDOTHELIUM INTERACTIONS 711
(Staunton el al., 1989a) or ICAM-3 (de Fougerolles 
et aLy 1991; de Fougerolles and Springer, 1992),
All three ICAM are members of the im­
munoglobulin superfamily, ICAM-1 has five Ig-like 
domains, ICAM-2 has two Ig-like domains, that are 
35 % identical to the two N-terminal domains of 
ICAM-1 (Staunton et al., 1990). Recent cloning of 
ICAM-3 revealed that it consists of five Ig-like do­
mains, 48 % identical to ICAM-1 and 31 % identi­
cal to ICAM-2 (Vazeux et al., 1992; Fawcett et a i ,  
1992). (32 integrins which bind immunoglobulin su­
perfamily counterreceptors recognize specific do­
mains within the counterreceptor (Staunton et aL, 
1990; Diamond et a l 1991). Recently, it has been 
described that the LFA-l/ICAM-1 interaction can 
also be inhibited by peptides (Dustin et a i ,  1986). 
In contrast to LFA-l, ICAM-1 is not exclusively ex­
pressed on leukocytes but on a wide variety of cells, 
including endothelial cells (Dustin et a l 3 1986). In­
flammatory mediators strongly induce ICAM -1 ex­
pression on endothelium (Dustin et ciL, 1986; Pober 
et a i ,  1986). ICAM-2 is found on haematopoietic 
cells and is highly expressed on endothelial cells. Its 
expression cannot be upregulated by inflammatory 
cytokines (Staunton et ai> 1989a; de Fougerolles et 
al., 1991). Because ICAM-2 expression is high on en­
dothelial venules in lymph nodes and vascular tissue, 
it has been hypothesized that it plays a role in leuko­
cyte trafficking through the lymph. ICAM-3 has thus 
far only been found on leukocytes. Because of its 
high expression on resting leukocytes, it is thought 
to play an important role in the initiation of the im­
mune response (de Fougerolles and Springer, 1992).
CR3 (C D llb /C D 18; Mac-1) consists of a 
170-kDa a-subunit and a 95-kDa (3-subunit. It is ex­
pressed at low levels on a subset of T lymphocytes, 
whereas expression on monocytes and granulocytes 
is high (Miller et a i ,  1986; Keizer et a l 1987). In 
resting monocytes and granulocytes, CR3 is stored 
in peroxidase-negative granules (Bainton et al., 1987). 
Activation of these cells by inflammation mediators 
results in rapid degranulation and increased surface 
expression of CR3 (Bainton et aL, 1987; Miller et a t ,  
1987). CR3 functions as a receptor for the comple­
ment component C3bi and mediates binding of 
unopsonized microorganisms (Wright et a i 3 1983). 
Other ligands of CR3 are fibrinogen, Factor X (fc X) 
and ICAM-1 (Loike et a l 3 1991; Diamond et a i s
1990). LFA-l and CR3 recognize distinct Ig domains 
on the ICAM-1 molecule (Diamond et al., 1991).
pl50,95 (CDllc/CD18) consists of a 150-kDa 
a-subunit and a 95-kDa (3-subunit. Like CR3, it is ex­
pressed on a small subset of lymphocytes, whereas 
it is present at high levels on monocytes, macro­
phages, granulocytes and dendritic cells (Miller et al., 
1986; Keizer et al.s 1987; Lanier et a i ,  1985). The 
a-subunit of p i 50,95 shows 63 % homology with the 
a-subunit of CR3. Like CR3, p i50,95 is stored in
peroxidase-negative granules (Bainton et al ., 1987). 
p i 50,95 binds to fibrinogen and C3bi (Loike et al., 
1991; Myones et a l ,  1988). No transmembrane 
ligand of p i 50,95 has yet been identified. Both 
pl50,95 and CR3 bind to denatured proteins (Davis,
1992), indicating that they are involved not only in 
cell-cell adhesion but also in cell-substrate adhesion.
(37 integrins a4/p7 (also called a4[3p) and HM L/p7 
have recently been identified on lymphocytes (Erie 
et al., 1991; Holzmann et a i ,  1989). Similar to a 4 /p i , 
a4/p7 binds to fibronectin as well as to VCAM-1 
(Ruegg et al., 1992).
Structure and function of integrins
Both a- and p-subunits of integrins are type I 
tran sm em b ran e  g lycoproteins with a single 
hydrophobic transmembrane segment and a short 
cytoplasmic tail. The extracellular domains of both 
subunits associate to form the aP heterodimers 
(Hynes, 1992). The characteristics of each subunit 
will be discussed in detail below (fig. 2).
The extracellular domains of the a- and P-subunits
The p-subunit of integrins contains a large ex­
tracellular domain consisting of 750 amino acids 
(p2 integrins). Characteristic of all p-subunits is a 
4-fold repeat of a cysteine-rich segment in the ex­
tracellular part of the p-subunit (fig. 2) (Kishimoto 
et al., 1989b). The N-terminus may be tightly folded 
due to internal disulphide bonding (fig, 3). The ex­
tracellular domain of the P-subunit contains a region 
of 100-200 amino acids that is highly conserved be­
tween different P-subunits. Point mutations in this 
area revealed that this region is important for a/p  as­
sociation and ligand binding (Kishimoto et al., 1989; 
Wardlaw et aL, 1990; Arnout et al.} 1990).
The a -su b u n its  are  also tra n sm e m b ra n e  
glycoproteins and have a large extracellular part 
(L F A -l: 1,150 amino acids). In the N-terminal part 
of the protein, a 7-fold repeat of a homologous seg­
ment is located. Three (P2 integrins) or four (almost 
all pi integrins) of these repeats at the C-terminai part 
contain a sequence which shows homology with the 
calcium binding proteins troponin C, calmodulin and 
parvalbumin (Tuckwell et a i ,  1992; Kirchhofer et al.3
1991). These repeats most likely contribute to the 
divalent cation-binding properties of the integrins 
(Kirchhofer et aLs 1991; Martz, 1980). This EF-h and 
m otif is made up of 13 residues, with a coordination 
typically supplied by residues 1, 3, 5, 7, 9 and 12 (Lar­
son et a i ,  1989; Kretsinger, 1980). The a-subunits 
o f the p2 integrins (C D lla-c) contain the metal- 
binding consensus nanopeptide DXDXDGXXD 
(D = aspartic acid, G = glycine, X = any amino acid)
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Fig. 2. Schematic diagram of the structure of (32 integrins.
>
The extracellular part of the a chain (aL) contains an I domain and 7 tandem repeats, of which 
three contain cation binding motifs (hatched). The extracellular part of the [3 chain ((32) contains 
four cystein-rich repeats (cross-hatched) and a 100-200 amino acid long region (stippled) which is 
highly conserved among the (3 subunits of integrins. (*) represents sites of naturally occurring amino 
acid substitutions or deletions in the (32 subunit, which results in impaired a(3 heterodimer forma­
tion, or the LAD syndrome. In the cytoplasmic tails of the a and (3 chain, serine (S), tyrosine (Y) 
and threonines (T) residues are mentioned which can be phosphorylated ( p ) upon PKC activation 
and are important for functional activity of LFA-1 (see text).
within these repeats, but lack the glutamic acid at po­
sition 12, as is found in other typical EF-hand mo­
tifs (Tuckwell et aL, 1992). It has been proposed that 
the glutamic acid residue, critical for cation binding, 
is provided by: 1) a segment in the a-subunit; 2) an 
oxygenated residue or segment within the (3-subunit, 
or; 3) an aspartate residue present in the ligands 
recognized by these receptors (Dransfield, 1991; 
Ginsberg et aL, 1991). Binding of the divalent cations 
Ca2+ and M g2+ is necessary for receptor function 
(Martz, 1980; Staatz et aL, 1989; Elices et al., 1991; 
Rothlein and Springer, 1986). They can modulate ot/(3 
associations as well as ligand binding affinity (Kirch- 
hofer et aL, 1991). Recently, a novel site within the 
I domain of CR3 (CD1 lb/CD18) has been shown to 
function as a divalent cation binding site, which 
seems essential for ligand binding (Michishita et aL,
1993). The a-subunit of the p2 family contains an in­
serted region (I domain), which shows homology to 
cartilage matrix protein, von Willebrand factor and 
complement factor B and C2. The I domain is 
thought to be a flexible recognition element within 
the a-chain, involved in ligand binding (Diamond et 
aL, 1993). Electron microscopic studies of the p3 inte­
grins revealed that the a /p  complex has a globular 
head with two tails. Similarities in structure are ex­
pected for the leukocyte-specific (32 integrins (fig. 3) 
(Carrell et aL, 1985; Dana et aL, 1991). Thus, the 
ligand binding site of the integrins seems to be formed 
by the cation domains and the I-domain within the 
a-subunit and the conserved region within the 
(3-subunit (fig. 3).
The intracellular domains of the a- and (3-subunits
The cytoplasmic domains of the integrins are 
thought to be important for receptor function. Both 
phosphorylation of the cytoplasmic domain and its 
induced association with the cytoskeleton may direct 
receptor activation through induction of a confor­
mational change. Interaction with cytoskeletal pro­
teins, to contribute to focal adhesion, is important 
for integrin function, since disruption of the 
cytoskeleton abolishes receptor-mediated adhesion 
(Reszka et aL, 1992; Pardi et aL, 1992b).
The cytoplasmic domain of the (3-subunits is short 
(47, 46 up to 52 amino acids, (31, (32 and (37, respec­
tively) and can interact with cytoskeletal proteins such 
as talin and a-actinin (¡31 and (32 integrins) (Pardi et 
aL, 1992b; Otey et aL, 1990; Burn et aL, 1988; 
Pavalko et aL, 1991; Pavalko and Burridge, 1991). 
Moreover, the cytoplasmic domains may also inter­
act with other cytoplasmic components (Brown et aL,
1990). Deletion of the cytoplasmic domain of the 
(31-(32-subunit can inactivate receptor function (Hibbs 
etaL, 1991a,b; Buyon etaL, 1990). Three threonine 
residues, which are highly conserved within the (31, 
¡32 and (37 integrin subfamilies, are most important 
for the p2 integrin receptor function (fig. 2) (Hibbs 
et aL, 1991b). Upon stimulation with PMA or fMLP, 
serine present in the cytoplasmic domain of the (32 
subunit is phosphorylated (Pardi et aL, 1992; Chatila 
et aL, 1989; Buyon et aL, 1990). Whether this phos­
phorylation affects receptor function is not known.
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the regulation of distinct post-receptor binding events 
(Shimizu and Shaw, 1991).
,  z“'
t
Regulation of lymphocyte adhesion
Lymphocytes are equipped with several mecha­
nisms to direct and regulate adhesion and migration 
to sites of inflammation (table II), First, upregula- 
tion or downregulation o f surface expression, or the 
state of glycosylation of particular adhesion recep­
tors is employed to control adhesive processes. 
Moreover, clustering of integrin receptors may in­
crease the avidity of cell-cell interactions. Enhanced 
receptor expression and receptor clustering on the cell 
surface do not necessarily correlate with enhanced 
adhesiveness of cells. This requires activation of the 
adhesion receptor itself, resulting in a higher affini­
ty for its ligand. Activation of integrins can be 
achieved through “ inside o u t55 signalling, whereby 
signals are generated from within the cell (Hynes, 
1992) (fig. 4). Activation of integrins involves con­
formational changes within the receptor, which lead 
to a higher affinity for its ligand, establishing cell- 
cell interaction. Binding of the ligand by the integrin ' 
can result in “ outside in ”  signalling, which may af­
fect migration or proliferation and differentiation of 
the cell (Shimizu and Shaw, 1991; Pardi et a! 
1992a). The following sections will describe each of 
these processes in more detail.
Fig. 3. Hypothetical three dimensional representation of
the LFA-1 molecule.
The a- and p-chain form two stalks extending from the 
lipid bilayer, with both N-terminals tightly folded to form 
a globular head. The ligand binding site seems to be formed 
by the cation binding domains and the I-domain within the 
a-subunit and the conserved region within the (3-subunit.
The short cytoplasmic domain of the a-subunit 
(ranging from 24 to 58 amino acids) has several 
potential phosphorylation sites. The LFA-1 a-chain 
is constitutively phosphorylated (Pardi et aL, 1992b; 
Chatila et aL, 1989; Buyon et at,, 1990). Hyper­
phosphorylation of the a-chain has been suggested 
to be associated with LFA-1 activation (Pardi et aL, 
1992). However, deletion of the cytoplasmic domain 
of the a-chain of the (52 integrins does not abrogate 
the capacity of LFA-1 to bind to ICAM-1 (Hibbs et 
aL, 1991a). This indicates that the cytoplasmic tail 
of the a-chain of the ¡32 integrins is not important 
for receptor activation. Characterization of the 
cytoplasmic domains of the a-chain of the pi inte­
grins revealed that these domains are important in
A) Regulation of lymphocyte adhesion by expression 
of receptors and ligands
Cell activation by cytokines or chemotactic fac­
tors can up- or down regulate cell surface expression. 
Expression of integrins on lymphocytes seems poor­
ly sensitive to cytokine treatment. Expression of the 
pi integrins is not affected by cytokine treatment, 
while LFA-1 expression (p2 integrin) is enhanced only 
2-fold by IL2 or IFNy (Shimizu et aL, 1990). On the 
other hand, expression of cellular ligands of integrin 
receptors is most sensitive to cytokines. Inflamma­
tory mediators, such as IFNy, IL1 and TNFa strongly 
induce ICAM-1 (Dustin et aL, 1986; Pober et aL, 
1986) or VCAM-1 expression (Osborn et al>, 1989) 
in a wide variety of tissue, such as endothelium, 
resulting in enhanced binding of lymphocytes (Dustin 
and Springer, 1988). In contrast, other ligands of 
LFA-1 (ICAM-2 and ICAM-3) seem less sensitive to 
inflammatory cytokines (Staunton et aL, 1989; de 
Fougerolles et aL, 1991; de Fougerolles and Springer,
1992). Differences in the state of glycosylation may 
also contribute to the capacity of adhesion receptors 
to bind to their ligand (Larson et aL, 1989; Dahms 
and Hart, 1986; Shimizu et aL, 1990a).
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Table II. Mechanisms that regulate (32-mediated cell adhesion.
Regulation at the level of Influenced by
A. Expression of receptors and their ligands
B. Affinity/avidity modulation of adhesion receptors
— “ inside ou t” signalling
— conformational changes
— clustering of receptors
— adhesion cascades
C. Signalling through adhesion receptors
— “ outside in” signalling
Cytokines, infectious agents, glycosylation
(De-)phosphorylation, second messengers 
Divalent cations, integrin mAb 
Divalent cations
Second messengers, kinase activity
Fig- 4. Activation and inactivation of integrins.
When the receptor is in an inactive state (closed), 
“ inside-out” signalling (1) can activate the receptor by in­
ducing a conformational change (2) whereby the open 
receptor can bind its ligand. Ligand occupation of the 
receptor can trigger intracellular events by Moutside-inn sig­
nalling (3). When signalling has stopped, the activated 
receptor can convert back into the inactive state.
B) Affinity avidity modulation of lymphocyte 
adhesion receptors 
“ Inside-out” signalling
A second mechanism to control cell adhesion is 
modulation of the affinity of the receptor for its 
ligand. Resting lymphocytes do not adhere spontane­
ously, but a variety of stimuli can induce (31-(VLA-4, 
-5, -6) or P2(LFA-1, CR3)-mediated cell-cell interac­
tions. Exposure of lymphocytes to phorbol ester 
(PMA) strongly induces (31- and (32-dependent cell 
adhesion, suggesting that activation o f protein 
kinase C (PKC) changes the affinity of these recep­
tors for their ligands (Martz, 1980; Rothlein and
Springer, 1986; Shimizu et aL, 1990). More recent­
ly, also, elevation of intracellular Ca2+ or cyclic 
AMP (cAMP) levels have been shown to activate the 
LFA-1 molecule (Haverstick and Gray, 1992a,b; van 
Kooyk et aL, 1993).
In addition, monoclonal antibodies directed 
against different cell surface structures expressed by 
T or B lymphocytes can stimulate LFA-1-mediated 
adhesion (table III). Triggering of these molecules ac­
tivates intracellular signalling pathways leading to 
LFA-1 activation, and subsequent enhanced ligand 
(ICAM-1) binding. The finding that activation of the 
CD2 and CD3 molecules results in LFA-1-mediated 
adhesion (Dustin and Springer, 1989; van Kooyk et 
aL, 1989) provides a link between TCR-mediated 
recognition of antigen and regulation of cell adhe­
sion (Figdor et aL, 1990). The observation that an 
increase in LFA-1 affinity induced by CD3 trigger­
ing is transient provides the cell with a mechanism 
to facilitate de-adhesion. Triggering of CD2 or CD3 
has been shown to activate [31 (VLA-4, -5, -6) 
(Shimizu et aL, 1990b). LFA-1 activation induced 
through triggering of CD2 or CD3 depends on PKC 
activation, PTK (protein tyrosine kinase) activity and 
cAMP levels (Dustin and Springer, 1989; van Koovk 
et aL, 1989). Also, increased intracellular Ca 
levels induced by CD2 or CD3 triggering directly 
correlate with the activated state of the LFA-1 recep­
tor (van Kooyk et aL, 1989). Recently, other reports 
have shown that antibodies directed against MHC 
class I or II (Spertini et aL, 1992), CD43 (Axelsson 
et aL, 1988), CD44 (Koopman et aL, 1990), CD28 
(Shimizu et aL, 1990b), CD7 (Shimizu et aL, 1990b) 
and CD31 (Tanaka et aL, 1992) expressed on T cells, 
and antibodies directed against CD 19 (Smith et aL,
1991), CD20, CD40 (Kansas and Tedder, 1991; Bar­
rett et aL, 1991) and MHC class II (Mourad et aL,
1990) expressed on B cells all induce LFA-1-mediated 
adhesion (table III). Depending on the surface recep­
tor triggered, different signal transduction pathways 
seem to be involved. These findings demonstrate that
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Table III. Inside-out signalling of p2 integrins.
Stimuli Type of cell 2nd Messenger 
Activating Inactivating
PMA T, B PKC
Forskolin B cAMP, PKA
Ionomycin T Ca2+j
LPS . j ,  *t, t B PKC, PKA
CD2 r ) T PKC, PTK, C a2 + j
CD3 T PKC, PTK, Ca2+j 
PKC
cAMP
CD7 r j i cAMP
CD19 B 9»
CD28 T PKC cAM P
CD31 T ?4
CD39 B cAMP
CD40 B ?*
CD43 T, B ?
CD44 T PKC
MHC cl 1 T, B PTK
MHC cl II T PKC, PTK, Ca2 + ;
(*) The addition of PMA, forskolin, ionomycin or LPS to B or T cells generates distinct 2nd messengers activating or inactivating 
LFA-1-mediated adhesion, (**) Cross-linking of distinct cell surface molecules, by mAb generates different messengers which regulate 
LFA-1 activation. PKC (protein kinase C), PTK (protein tyrosine kinase), Ca2 + i (intracellular C a 2+ mobilization), cAMP (cyclic adenosine 
mono-phosphate).
activation of LFA-1 can be induced through trigger­
ing of different surface receptors, and illustrate that 
the LFA-1/ICAM -1 pathway is a common adhesion 
pathway that may be utilized by lymphocytes under 
quite different physiological conditions.
Intramolecular alterations (conformational changes)
An increasing amount of evidence indicates that 
activation of pi P2 is accompanied by a conforma­
tional change within the integrin molecule.
1) Unique monoclonal antibodies have been 
described that recognize integrins only in their acti­
vated state (active conformation). This is determined 
by the expression of neoepitopes on the integrin or 
the expression of a ligand-induced binding site (LIBS) 
on the integrin, which appears upon binding of their 
ligand (Dransfield et aL, 1992a,b; van Kooyk et aL,
1991).
2) Binding of Mg2+ to LFA-1 possibly induces a 
conformational change, as detected by enhanced 
reactivity with a certain mAb 24 (Dransfield and 
Hogg, 1989), Also binding of Ca2+ to LFA-1 can 
alter the configuration of LFA-1, as detected by en­
hanced reactivity with mAb NKI-L16 (van Kooyk et
aL, 1991 ; and submitted). Extracellular binding of 
M n2+ (Dransfield et aL, 1992a; Altieri, 1991) 
and/or C o2+ (Dransfield et aL, 1990) can induce a 
conformational change in both pi and p2 integrins, 
which leads to an increased affinity of the receptor 
for its ligand.
3) Phosphorylation or déphosphorylation of the 
cytoplasmic tails of the p2 or pi integrins (a- or 
P-subunit) or cytoskeletal components may induce a 
conformational change in the integrin (Pardi et aL,
1992).
4) Specific antibodies directed against the pi and 
P2 integrins that enhance instead of inhibit adhesion 
have been described. Also, Fab fragments o f these 
mAb enhance integrin-mediated adhesion which 
demonstrates that cross-linking of receptors is not re­
quired. Binding o f  these mAb most likely results in 
a conformational change in the adhesion receptor, 
thus increasing the affinity for its ligand. For exam­
ple, mAb directed against a C a2+-dependent epitope 
located on the LFA-1 oc-subunit (van Kooyk et aL, 
1991 ; Keizer et aL, 1988 ; van Kooyk, unpublished) 
and mAb directed against an epitope on the common 
P2-subunit (Robinson et at., 1992) enhance binding 
of LFA-1 to ICAM-1. Similarly, mAb directed 
against the VLA-4 a -ch a in  can enhance
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VLA-4-dependent cell aggregation (Campanero et 
al., 1990). However, unique anti-(31 mAb can also 
stimulate binding of VLA-4 to VCAM-1 as well as 
binding of leukocyte to ECM components (Kovach 
et al., 1992; van de Wiel van Kemenade et al., 1992). 
This indicates that antibodies directed against the a- 
or [3-subunit can activate integrins by inducing a con­
formational change.
Clustering of receptors
Clustering of adhesion receptors has been shown 
to be important in facilitating integrin-ligand inter­
action. Clustering of CR3 receptors has been reported 
to be temporally correlated with its ability to bind 
their ligand (Detmers et al., 1987). Moreover, bind­
ing of Ca2+ to LFA-1 is associated with clustering 
of receptors on the cell membrane, which facilitates 
LFA-1 activation by increasing the avidity of 
LFA-l-ligand interaction (van Kooyk, unpublished).
Adhesion cascades
Several experiments indicate that adhesion 
molecules may operate successively in time. For 
example, leukocyte adhesion to endothelium at sites 
of inflammation is a multistep process initially in­
volving unstable adhesion, followed by stable adhe­
sion by (32 integrins and finally strong adhesion of 
P2 integrins to their counterreceptors. Different 
examples can be given of adhesion cascades leading 
to stable cell-cell binding.
Recognition of antigen by lymphocytes is medi­
ated by the T-cell receptor-antigen/MHC interaction, 
which precedes.stable LFA-1/ICAM-1 interaction. 
Similarly, CD2/LFA-3 interaction may activate the 
LFA-l/ICAM-1 interaction (van de Wiel van 
Kemenade et al., 1992). Also CD44, which may play 
a role in lymphocyte homing, can stimulate the 
LFA-1 adhesion pathway (Koopman et al., 1990).
Selectins or ‘‘rolling receptors” act very early in 
the adhesion cascades (Lawrence and Springer, 1991; 
Lawrence et aL, 1990; Lo et aL} 1991). They enable 
rolling of neutrophils along the endothelial cells, 
thereby reducing their speed. By bringing the neu­
trophil into close proximity of the endothelial cell, 
(32-mediated binding (CR3) to endothelium is facili­
tated (Lo et al., 1991). More recently, it has been 
described that cytokines can be immobilized by pro­
teoglycans present on endothelial cells which trigger 
VLA-4-mediated adhesion of specific lymphocyte 
subsets and thus regulate adhesion and migration of 
lymphocytes through endothelium (Tanaka et al.,
1993).
C) Signalling through adhesion receptors 
“ Outside-in” signalling
In addition to regulation of the receptor affinity 
by signals generated inside the cell, an increasing 
amount of evidence indicates that adhesion receptors 
themselves can transmit signals into the cell 
(‘4outside-in’’ signalling). The use of monoclonal an­
tibodies or purified immobilized ligands to cross-link 
specific integrin receptors, has identified cell adhe­
sion molecules as signal transducer molecules.
Clustering of [32 integrins by antibodies directed 
against the LFA-1 or CR3 a-subunit results in release 
of intracellular Ca2+ as well as an increase in in­
tracellular pH (Ng Sikorski et al., 1991; Schwartz et 
a l ,  1991b; Pardi et a l ,  1989; Richter et aL, 1990). 
Clustering of (31 receptors by mAb directed against 
the pi-subunit can cause tyrosine phosphorylation of 
a 115-kDa molecular complex (Kornberg et al., 1991). 
Moreover, ligation of VLA-4 on T cells stimulates 
tyrosine phosphorylation of a 105-kDa protein, in­
dicating that engagement of VLA-4 on T cells acti­
vates protein-tyrosine kinase (PTK) activity (Nojima 
et al., 1992). Indeed-specific protein-tyrosine kinases 
have been identified, which are concentrated in fo­
cal adhesions (FAK, or focal adhesion kinases), and 
which are phosphorylated in response to cell attach­
ment to ECM components (Hanks et a l 1992).
Binding of pi integrins to FN induces clustering 
of the integrins and activates the Na + /H  + anti­
porter (Schwartz et al., 1991a). In addition, ligation 
of LFA-1 on B cells improves the ability to present 
antigen to the T cells (Moy and Brian, 1992). Ad­
herence of neutrophils via P2 integrins together with 
cytokines induces a respiratory burst and cell motil­
ity (Jaconi et al., 1991). Furthermore, monocyte 
adhesion seems to be associated with PLC activation, 
whereas intracellular Ca2+ mobilization plays a role 
in cell spreading (Lefkowith et al., 1992). Several 
reports have indicated that anti-LFA-l-a antibodies 
(van Seventer etaL, 1991c; van Noesel et al., 1988), 
anti-ICAM-1 (van Seventer et al,, 1991a; Cerdan et 
al,, 1989) or anti-ICAM-2 antibodies (Damle et a i ,
1992) enhance lymphocyte proliferation, when im­
mobilized together with anti-CD3 antibodies 
(costimulation) (van Seventer et al., 1990). Anti- 
(32-subunit antibodies were ineffective, suggesting 
that the a- and P-subunits of LFA-1 may have dis­
tinct signalling properties. VLA-4 as well as its cel­
lular ligand VCAM-1, can also provide costimulatory 
signals (van Seventer et a i ,  1991a; Burkly et al., 
1991; Damle and Aruffo, 1991).
Cross-linking of integrins by antibodies mimics 
the engagement of receptor with its ligand and af­
fects cytoskeletal organization. “ Outside in” signall­
ing through adhesion receptors is mediated by 
different intracellular messengers and /or cytoskele-
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tal components, and may contribute directly to cell 
maturation, differentiation and proliferation (Pardi 
et al., 1992; van Seventer et al., 1991b).
Role of lymphocyte adhesion receptors in vivo
The importance of adhesion receptors in vivo is 
best illustrated in patients suffering from the leuko­
cyte adhesion deficiency (LAD) syndrome (Staatz et 
al., 1989; Springer et a i , 1984; Anderson and 
Springer, 1987; Kishimoto et a l ,  1987; Todd and 
Freyer, 1988; Fischer et al., 1985), a genetic deficien­
cy of the (32 integrin receptor caused by mutations 
in the common (32 subunit (fig. 2) (Kishimoto et al 
1989; Wardlaw et al., 1990; Arnaout et aL, 1990). 
The LAD syndrome results in the absence of LFA-1, 
CR3 and pl50,95 on the cell surface of leukocytes. 
Patients have recurring, life-threatening bacterial in­
fections, and severe defects in adhesion-dependent 
leukocyte functions, which are often fatal in child­
hood, unless they can be corrected by bone marrow 
transplantation (Fischer et a i , 1988). The potential 
of mAb directed against integrins or their counter­
receptors to reduce vascular and tissue damage in a 
variety of clinical disorders, has been examined (acute 
and chronic allograft rejection, rheumatoid arthri­
tis, inflam m atory skin disease, asthma and 
ischaemia-reperfusion syndromes). Inhibition of leu­
kocyte adhesion processes by ‘ 'anti-adhesion’ ’ ther­
apy represents a novel approach to treat disorders 
in which leukocytes contribute significantly to vas­
cular and tissue damage (Carlos and Harlan, 1990).
In vivo treatment with anti-VLA-4 antibodies 
inhibits migration of lymphocytes to cutaneous 
inflammatory sites (Issekutz, 1991). Anti-ICAM-1 
antibodies have been shown to reduce airway inflam­
mation, hyperresponsiveness and asthma symptoms 
(Wegner et al., 1990). Moreover, a soluble form of
I CAM-1, as well as anti-ICAM-1 antibodies inhibit 
rhinovirus infections, which cause 50 % of common 
colds (Marlin et al., 1990). ICAM-1 has been identi­
fied as the cellular receptor for a subgroup of 
rhinoviruses (Staunton et a i ,  1989b; Greve et at.,
1989) and is one of the receptors for Plasmodium f a l  
c//?a/‘w/77(malaria)-infected erythrocytes (Ockenhouse 
et al., 1992; Berendt et al., 1992).
It has been demonstrated that anti-CD 18 anti­
bodies prevent ischaemia-reperfusion injury (Vedder 
et al., 1988), whereas anti-C D llb antibodies reduce 
infarct size in a canine model (Simpson et al., 1988). 
Administration of anti-LFA-1 antibodies enhances 
different tissue transplant survival (Heaggy and 
Waltenbaugh, 1983; van Dijken et al., 1990; Harning 
et al., 1991), whereas anti-ICAM-1 antibodies have 
been demonstrated to extend kidney and heart trans­
plant survival in monkeys in the absence of tolerance 
induction (Cosimi et al., 1990; Flavin et al., 1991).
A combination of anti-LFA-1 and anti-ICAM-1 mAb 
leads to tolerance in heart transplantation in mice 
(Isobe et al., 1992); however tolerance is not observed 
in skin transplants (van Kooyk e t al., unpublished). 
Pilot studies in humans revealed that anti-LFA-1 
mAb prevented acute rejection of kidney transplants 
without induction of tolerance (Le M auff, unpub­
lished) .
Conclusions
These findings demonstrate that adhesion recep­
tors play an important role in different immunologic 
reactions. Leukocyte-specific adhesion receptors such 
as LFA-1 show a dynamic nature by the presence of 
distinct conformational changes, which can be regu­
lated extracellularly by divalent cations or ligand 
binding, and intracellularly by the generation of dis­
tinct signals. The usage of mAb directed against these 
receptors or their ligands in vivo  by an anti-adhesion 
therapy demonstrates a promising reduction in tis­
sue destruction, caused by disease or by inflamma­
tory responses. Future experiments will determine if 
combinations of antibodies directed against distinct 
adhesion receptors will give optimal acceptance of 
tissue transplants.
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